Molecularly Targeted Therapy Using Bevacizumab for Non-Small Cell Lung Cancer: a Pilot Study for the New CT Response Criteria

OBJECTIVE: We wanted to compare the efficacy of the new CT response evaluation criteria for predicting the tumor progression-free survival (PFS) with that of RECIST 1.1 in non-small cell lung cancer (NSCLC) patients who were treated with bevacizumab. MATERIALS AND METHODS: Sixteen patients (M:F = 11...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ho Yun, Lee, Kyung Soo, Hwang, Hye Sun, Lee, Ju Won, Ahn, Myung-Ju, Park, Keunchil, Kim, Tae Sung, Yi, Chin A, Chung, Myung Jin
Formato: Texto
Lenguaje:English
Publicado: The Korean Society of Radiology 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2974223/
https://www.ncbi.nlm.nih.gov/pubmed/21076587
http://dx.doi.org/10.3348/kjr.2010.11.6.618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2974223/
https://www.ncbi.nlm.nih.gov/pubmed/21076587
http://dx.doi.org/10.3348/kjr.2010.11.6.618

Ejemplares similares